From Clinical Thyroidology® for the Public: Graves’ disease is an autoimmune disease, meaning that the body makes antibodies that attack and turn on the thyroid, causing the hyperthyroidism. These antibodies can be measured in the blood and have become valuable in confirming the diagnosis of Graves’ disease and in determining relapse risk and duration of antithyroid drug treatment. In this study, the researchers investigate the association between TPOAb and TgAb concentrations and disease relapse in patients with newly diagnosed Graves’ disease managed with antithyroid drugs. Read More…
We welcome your feedback and suggestions. Let us know what you want to see in this publication.
Feedback & Suggestions
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.